KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
61 hedge funds and large institutions have $171M invested in Kindred Biosciences, Inc. in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $102K
Holders
61
Holding in Top 10
1
Calls
–
Puts
$102K
Top Buyers
| 1 | +$1.58M | |
| 2 | +$517K | |
| 3 | +$473K | |
| 4 |
BlackRock
New York
|
+$404K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$380K |
Top Sellers
| 1 | -$3.63M | |
| 2 | -$2.45M | |
| 3 | -$1.54M | |
| 4 |
PGC
Pacific Grove Capital
San Francisco,
California
|
-$1.48M |
| 5 |
Renaissance Technologies
New York
|
-$943K |